The anxieties of drug discovery and development. CCK-B receptor antagonists.
Central Research Division, Pfizer Inc., Groton, Connecticut 06340, USA.
F
F
Lombardo
S M
SM
Winter
L
L
Tremaine
J A
JA
Lowe
D000818:Animals; D001812:Blood-Brain Barrier; D015195:Drug Design; D006801:Humans; D007408:Intestinal Absorption; D043887:Receptor, Cholecystokinin B; D011949:Receptors, Cholecystokinin / Q000037:antagonists & inhibitors*; D012995:Solubility; D013329:Structure-Activity Relationship
D043887:Receptor, Cholecystokinin B; D011949:Receptors, Cholecystokinin